CRED Managing Variations Effectively

MAHs of medicinal products are reminded of the legal repercussions which need to be considered when the UK becomes third country . Batch release/importation , Quality/Batch control for FP currently performed by UK sites for medicinal products for the EU/EEA market, need to be transferred to sites located in other MS before 30 th March 2019 , through the submission of the corresponding variations.

87